7, 8-Dihydroxycoumarin (daphnetin) Protects INS-1 Pancreatic Β-Cells Against Streptozotocin-Induced Apoptosis.

Ramachandran Vinayagam,Baojun Xu
DOI: https://doi.org/10.1016/j.phymed.2016.11.023
IF: 6.656
2017-01-01
Phytomedicine
Abstract:Background and objective: Daphnetin (7, 8-dihydroxycoumarin), a natural coumarin compound, is known to exhibit antioxidant and anti-inflammatrory effects. However, the underlying mechanisms of its antiapoptotic and antidiabetic effects yet not been examined. Therefore, the present work studied the antiapoptotic and anti-diabetic effects of daphnetin by in vitro experiments.Methods: The rat insulinoma (INS-1) cells were pre-treated with daphnetin at different concentrations (1, 10, 20 and 40 mu M) for 24 h followed by exposition to streptozotocin (STZ) (3 mM) for 12 h. Effects of daphnetin and STZ on INS-1 cells were determined by MTT assay, glucose stimulated insulin secretion (GSIS) assay, lipid peroxidation, antioxidant status (SOD, CAT, GPx, and GST) Apoptosis staining (DAPI, Hoechst 33342, AO/EB and ROS) was performed by fluorescence microscopy, and Bcl-2, Bax and NF-kappa B protein expression was detected by Western blotting.Results: MTT assay indicated that the viability of INS-1 cells was significantly reduced with exposure to STZ for 12 h as compared to control cells, while pre-treated with daphnetin for 24 h resulted in a significant improvement of cell viability. The effects daphnetin treatment in INS-1 cells on insulin secretion was tested and results showed that the pre-treatment of daphnetin could improve GSIS. Further, daphnetin pre-treatment significantly reduced the levels of lipid peroxidation markers and also improved antioxidant enzymes' activities in STZ-induced INS-1 cells. Western blotting assay revealed that daphnetin could suppress apoptosis through up-regulation of anti-apoptotic Bcl-2 protein expression and the down-regulation of pro-apoptotic Bax and nuclear factor NF-kappa B protein levels.Conclusion: The results showed that daphnetin might be used in treating diabetes due to its insulin stimulating property and subsequent regulation of apoptotic pathway. (C) 2016 Elsevier GmbH. All rights reserved.
What problem does this paper attempt to address?